Garrett Collins, MD
Internal Medicine · Augusta, GANPI 1699124818
Payments from drug & device makers
Across 98 payments — averaging $69.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- GSK$554
- Boehringer Ingelheim$289
- AstraZeneca$206
- Sanofi$201
- United Therapeutics Corporation$172
- plus $1K from 17 others
What the payments were for
- Travel & lodging$2383%
- Food & beverage$2,42935%
- Education$4,17961%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $4,362 |
| GSK | 29 | $554 |
| Boehringer Ingelheim | 7 | $289 |
| AstraZeneca | 6 | $206 |
| Sanofi | 6 | $201 |
| United Therapeutics Corporation | 5 | $172 |
| Pulmonx Corporation | 3 | $166 |
| Mallinckrodt Hospital Products Inc. | 3 | $161 |
| Insmed, Inc. | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| Merck | 2 | $60 |
| Grifols USA, LLC | 2 | $55 |
| Pfizer | 3 | $47 |
| Johnson & Johnson | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Verona Pharma, Inc. | 1 | $29 |
| Amgen | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Bayer | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,232
- ANDEXXA$125
- OFEV$122
How this compares
$6,846 in reported general payments places this provider in the 90th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $35,830 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 22 | $11,206 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $9,395 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $6,735 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $4,663 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $2,104 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 87 | $2,094 |
| Varenicline Tartrate | 12 | $1,951 |
| Prednisone | 23 | $123 |
| Montelukast Sodium | 25 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $554 | $51,96091 claims |
| Boehringer IngelheimStiolto Respimat | $289 | $11,20622 claims |
| AstraZenecaSymbicort | $206 | $4,66322 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Augusta
- Jon GibbsAugusta$172K
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.